Found: 5
Select item for more details and to access through your institution.
Toxicological and bio-distribution profile of a GM-CSF-expressing, double-targeted, chimeric oncolytic adenovirus ONCOS-102 – Support for clinical studies on advanced cancer treatment.
- Published in:
- PLoS ONE, 2017, v. 12, n. 8, p. 1, doi. 10.1371/journal.pone.0182715
- By:
- Publication type:
- Article
T-cell Subsets in Peripheral Blood and Tumors of Patients Treated With Oncolytic Adenoviruses.
- Published in:
- Molecular Therapy, 2015, v. 23, n. 5, p. 964, doi. 10.1038/mt.2015.17
- By:
- Publication type:
- Article
Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors.
- Published in:
- International Journal of Cancer, 2012, v. 130, n. 8, p. 1937, doi. 10.1002/ijc.26216
- By:
- Publication type:
- Article
Immunological Effects of Low-dose Cyclophosphamide in Cancer Patients Treated With Oncolytic Adenovirus.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 9, p. 1737, doi. 10.1038/mt.2011.113
- By:
- Publication type:
- Article
Treatment of Cancer Patients With a Serotype 5/3 Chimeric Oncolytic Adenovirus Expressing GMCSF.
- Published in:
- Molecular Therapy, 2010, v. 18, n. 10, p. 1874, doi. 10.1038/mt.2010.161
- By:
- Publication type:
- Article